Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Epithelial-mesenchymal transition (EMT) is a phenotypic conversion that facilitates organ morphogenesis and tissue remodeling in physiological processes, such as embryonic development and wound healing. A similar phenotypic conversion is also detected in fibrotic diseases and neoplasia, and is associated with disease progression. EMT in cancer epithelial cells often seems to be an incomplete and bidirectional process. In this Review, we discuss the phenomenon of EMT as it pertains to tumor development, focusing on exceptions to the commonly held rule that EMT promotes invasion and metastasis. We also highlight the role of RAS-controlled signaling mediators, ERK1, ERK2 and phosphatidylinositol 3-kinase, as microenvironmental responsive regulators of EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MSCs facilitate and modulate EMT through the production of regulatory molecules, namely TGF-b, E-cadherin and micro-RNA, resulting in more invasive phenotype [46], [47].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“70-gene prognostic signature CCL2, MT1X and MT2A van‘t Veer et al. (2002)46”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Self-citationLarue, L., & Bellacosa, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209091 · Cited by 1,228
Liu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K., & Clarke, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063994 · Cited by 985
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J.-T., Rijn, M. V. D., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 951
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
The signaling mechanism of ROS in tumor progression
Wu, W.-S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9037-8 · Cited by 752
ERK implication in cell cycle regulation
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 750
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis
Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., & Grünert, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109037 · Cited by 706
Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition
Savagner, P. (2001) · BioEssays · doi:10.1002/bies.1132 · Cited by 679
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis
Grünert, S., Jechlinger, M., & Beug, H. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1175 · Cited by 678
Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1861 · Cited by 655
Self-citationThe stress-activated protein kinase pathways
Tibbles, L. A., & Woodgett, J. R. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050369 · Cited by 643
Tissue Geometry Determines Sites of Mammary Branching Morphogenesis in Organotypic Cultures
Nelson, C. M., VanDuijn, M. M., Inman, J. L., Fletcher, D. A., & Bissell, M. J. (2006) · Science · doi:10.1126/science.1131000 · Cited by 608
Self-citationSmad3 as a mediator of the fibrotic response
Flanders, K. C. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00377.x · Cited by 608
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior
Desmouliere, A., Guyot, C., & Gabbiani, G. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041802ad · Cited by 551
Genetic programs of epithelial cell plasticity directed by transforming growth factor-β
Zavadil, J., Bitzer, M., Liang, D., Yang, Y.-C., Massimi, A., Kneitz, S., Piek, E., & Böttinger, E. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111614398 · Cited by 536
The Fallacy of Epithelial Mesenchymal Transition in Neoplasia
Tarin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0699 · Cited by 531
Brabletz, T., Hlubek, F., Spaderna, S., Schmalhofer, O., Hiendlmeyer, E., Jung, A., & Kirchner, T. (2005) · Cells Tissues Organs · doi:10.1159/000084509 · Cited by 528
Epithelial Origin of Myofibroblasts during Fibrosis in the Lung
Willis, B. C., duBois, R. M., & Borok, Z. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-004tk · Cited by 500
Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Fibroblasts and myofibroblasts: Their source, function and role in disease
McAnulty, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.11.005 · Cited by 456
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?
Radisky, D. C., Kenny, P. A., & Bissell, M. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21186 · Cited by 344
Self-citationNawshad, A., LaGamba, D., Polad, A., & Hay, E. D. (2005) · Cells Tissues Organs · doi:10.1159/000084505 · Cited by 327
Alonso, S. R., Tracey, L., Ortiz, P., Pérez-Gómez, B., Palacios, J., Pollán, M., Linares, J., Serrano, S., Sáez-Castillo, A. I., Sánchez, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3481 · Cited by 326
Epithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma
Petersen, O. W., Nielsen, H. L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M. J., & Rønnov-Jessen, L. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63834-5 · Cited by 305
Self-citationThe epithelial-mesenchymal tansition (EMT) and colorectal cancer progression
Bates, R. C., & Mercurio, A. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.4.1655 · Cited by 298
Exploring a New Twist on Tumor Metastasis
Yang, J., Mani, S. A., & Weinberg, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3850 · Cited by 297
A stromal address code defined by fibroblasts
Parsonage, G., Filer, A. D., Haworth, O., Nash, G. B., Rainger, G. E., Salmon, M., & Buckley, C. D. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.11.014 · Cited by 297
Expression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294 · cited 2×
“Based on data from Jechlinger M et al. (2003) Oncogene 22: 7155–7169, and LaGamba D et al.”
MethodOncogenic Ras in tumour progression and metastasis
Giehl, K. (2005) · Biological Chemistry · doi:10.1515/bc.2005.025 · Cited by 287
Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia
Gudjonsson, T., Adriance, M. C., Sternlicht, M. D., Petersen, O. W., & Bissell, M. J. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9586-4 · Cited by 281
Self-citationSavagner, P., Kusewitt, D. F., Carver, E. A., Magnino, F., Choi, C., Gridley, T., & Hudson, L. G. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20188 · Cited by 269
Myoepithelial cells: good fences make good neighbors
Adriance, M. C., Inman, J. L., Petersen, O. W., & Bissell, M. J. (2005) · Breast Cancer Research · doi:10.1186/bcr1286 · Cited by 262
Self-citationHiscox, S., Jiang, W. G., Obermeier, K., Taylor, K., Morgan, L., Burmi, R., Barrow, D., & Nicholson, R. I. (2006) · International Journal of Cancer · doi:10.1002/ijc.21355 · Cited by 260
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Chung, C. H., Parker, J. S., Ely, K., Carter, J., Yi, Y., Murphy, B. A., Ang, K. K., El-Naggar, A. K., Zanation, A. M., Cmelak, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1213 · Cited by 249
Gee, J. M. W., Robertson, J. F. R., Ellis, I. O., & Nicholson, R. I. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s · Cited by 249
Lien, H. C., Hsiao, Y. H., Lin, Y. S., Yao, Y. T., Juan, H. F., Kuo, W. H., Hung, M.-C., Chang, K. J., & Hsieh, F. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210593 · Cited by 225
Han, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
Vincent-Salomon, A., & Thiery, J. P. (2003) · Breast Cancer Research · doi:10.1186/bcr578 · Cited by 223
Aroeira, L. S., Aguilera, A., Selgas, R., Ramírez-Huesca, M., Pérez-Lozano, M. L., Cirugeda, A., Bajo, M. A., del Peso, G., Sánchez-Tomero, J. A., Jiménez-Heffernan, J. A., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.011 · Cited by 208
Vallés, A. M., Boyer, B., Badet, J., Tucker, G. C., Barritault, D., & Thiery, J. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1124 · Cited by 207
Predicting a local recurrence after breast-conserving therapy by gene expression profiling
Nuyten, D. S., Kreike, B., Hart, A. A., Chi, J.-T. A., Sneddon, J. B., Wessels, L. F., Peterse, H. J., Bartelink, H., Brown, P. O., Chang, H. Y., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1614 · Cited by 202
Mechanisms of Disease: fibroblasts—a new look at an old problem
Neilson, E. G. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0093 · Cited by 200
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
Janes, P. W., Daly, R. J., DeFazio, A., & Sutherland, R. L. (1994) · PubMed · Cited by 199
Tolg, C., Hamilton, S. R., Nakrieko, K.-A., Kooshesh, F., Walton, P., McCarthy, J. B., Bissell, M. J., & Turley, E. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511027 · Cited by 175
Self-citationLinking oncogenic pathways with therapeutic opportunities
Bild, A. H., Potti, A., & Nevins, J. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1976 · Cited by 163
Lochter, A., Srebrow, A., Sympson, C. J., Terracio, N., Werb, Z., & Bissell, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5007 · Cited by 151
Self-citationEpithelial-mesenchymal transition in gastric cancer (Review)
Katoh, M. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.6.1677 · Cited by 138
Prindull, G., & Zipori, D. (2004) · Blood · doi:10.1182/blood-2003-08-2807 · Cited by 136
Fournier, M. V., Martin, K. J., Kenny, P. A., Xhaja, K., Bosch, I., Yaswen, P., & Bissell, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0515 · Cited by 128
Self-citationNovel roles for chemokines and fibroblasts in interstitial fibrosis
Hogaboam, C. M., Steinhauser, M. L., Chensue, S. W., & Kunkel, S. L. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00176.x · Cited by 127
Sorting Out Breast-Cancer Gene Signatures
Massagué, J. (2007) · New England Journal of Medicine · doi:10.1056/nejme068292 · Cited by 127
The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion.
PETERSEN, O. W., Nielsen, H. L., Guðjónsson, Þ., Villadsen, R., Rønnov‐Jessen, L., & Bissell, M. J. (2001) · Breast Cancer Research · doi:10.1186/bcr298 · Cited by 123
Self-citationRastaldi, M. P. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.4.407 · Cited by 116
Origin of Interstitial Fibroblasts in an Accelerated Model of Angiotensin II-Induced Renal Fibrosis
Faulkner, J. L., Szcykalski, L. M., Springer, F., & Barnes, J. L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61208-4 · Cited by 113
Milde-Langosch, K., Bamberger, A.-M., Rieck, G., Grund, D., Hemminger, G., Müller, V, & Löning, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602655 · Cited by 110
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A., & Venanzi, F. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l · Cited by 105
Dong, Y., Sui, L., Sugimoto, K., Tai, Y., & Tokuda, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<209::aid-ijc1036>3.0.co;2-r · Cited by 93
Biological and clinical associations of c-jun activation in human breast cancer
Gee, J. M. W., Barroso, A. F., Ellis, I. O., Robertson, J. F. R., & Nicholson, R. I. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<177::aid-ijc13>3.0.co;2-0 · Cited by 89
Microarray analysis of gene expression during epithelial–mesenchymal transformation
LaGamba, D., Nawshad, A., & Hay, E. D. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20489 · Cited by 87
Shintani, Y., Wheelock, M. J., & Johnson, K. R. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1123 · Cited by 86
The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis
Malaney, S., & Daly, R. J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009572700317 · Cited by 85
Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
Kim, D., Cheng, G. Z., Lindsley, C. W., Yang, H., & Cheng, J. Q. (2005) · PubMed · Cited by 81
Carrozzino, F., Soulié, P., Huber, D., Mensi, N., Orci, L., Cano, A., Féraille, E., & Montesano, R. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00175.2005 · Cited by 81
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases.
Zvaifler, N. J. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1963 · Cited by 75
Maintenance of Head and Neck Tumor Gene Expression Profiles upon Lymph Node Metastasis
Roepman, P., Jager, A., Koerkamp, M. J. A. G., Kummer, J. A., Slootweg, P. J., & Holstege, F. C. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3161 · Cited by 69 · cited 1×
“Stromal signature of HNSCC (human) Pcolce Roepman et al. (2006)30”
Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line
Boyer, B., Tucker, G. C., Vallés, A. M., Gavrilović, J., & Thiery, J. P. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440719 · Cited by 59
Genotype-Phenotype Correlations as a Guide in the Management of Familial Adenomatous Polyposis
Nieuwenhuis, M. H., Mathus-Vliegen, L., Slors, F. J. M., Griffioen, G. G., Nagengast, F. M., Schouten, W. R., Kleibeuker, J. H., & Vasen, H. F. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.014 · Cited by 59
Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes
Hudson, L. G., Choi, C., Newkirk, K. M., Parkhani, J., Cooper, K. L., Lü, P., & Kusewitt, D. F. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20257 · Cited by 58
A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival
Bacac, M., Provero, P., Mayran, N., Stehle, J.-C., Fusco, C., & Stamenkovic, I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000032 · Cited by 53 · cited 1×
“Stromal response of prostate cancer (mouse) Mt2 Bacac et al. (2006)31”
BackgroundIn the pursuit of complexity: Systems medicine in cancer biology
Liu, E. T., Kuznetsov, V. A., & Miller, L. D. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.026 · Cited by 50 · cited 1×
“‘Invasiveness’ gene signature Ier5 and Fln Liu et al. (2007)92”
Rationale for Ras and Raf-kinase as a Target for Cancer Therapeutics
Nottage, M. K., & Siu, L. L. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393107 · Cited by 34
From Description to Causality: Mechanisms of Gene Expression Signatures in Cancer
Adler, A. S., & Chang, H. Y. (2006) · Cell Cycle · doi:10.4161/cc.5.11.2798 · Cited by 20
Maintenance of Cell Type Diversification in the Human Breast
Fridriksdottir, A. J., Villadsen, R., Guðjónsson, Þ., & PETERSEN, O. W. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-2541-6 · Cited by 18
Nakopoulou, L., MYLONA, E., Rafailidis, P. I., Alexandrou, P., Giannopoulou, I., & Keramopoulos, A. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_236.x · Cited by 15
Transdifferentiation of neoplastic cells
Zhang, Z., Yuan, X., Li, L.-H., & Xie, F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1435 · Cited by 10
Prognostic Value of Mutations in TP53 and RAS Genes in Breast Cancer
Guerra, E., Vacca, G., Palombo, B., & Alberti, S. (2003) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.3870 · Cited by 9
Cited by
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A. G., Slaby, O., et al. (2019) · Cancers · doi:10.3390/cancers11101618 · Cited by 944
“The responsiveness of RAS in the TME frequently implies a phenotypic modification of the tumor cell toward a migratory status, through the loss of cell-to-cell adhesion via EMT and its related effectors in tumor cells [83].”
BackgroundInfluentialUlrich, T. A., de Juan Pardo, E. M., & Kumar, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4859 · Cited by 901
“Importantly, many of these pathways have also been implicated in epithelial-mesenchymal transition (48).”
BackgroundFGF Receptors: Cancer Biology and Therapeutics: CANCER BIOLOGY AND THERAPEUTICS ON FGF RECEPTORS
Katoh, M., & Nakagama, H. (2014) · Medicinal Research Reviews · doi:10.1002/med.21288 · Cited by 610
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Wang, H., Li, Z.-Y., Liu, Y., Persson, J., Beyer, I., Möller, T., Koyuncu, D., Drescher, M. R., Strauss, R., Zhang, X.-B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2270 · Cited by 432
“EMT is characterized by increased expression of mesenchymal markers, increased expression of extracellular matrix compounds, decreased expression of epithelial markers, altered location of transcription factors, and activation of kinases 7.”
Metadata
- Authors
- Turley, E. A., Veiseh, M., Radisky, D. C., & Bissell, M. J.
- Affiliations
- Western University (CA)
- Lawrence Berkeley National Laboratory (US)
- Mayo Clinic in Florida (US)
- Corresponding author
- Bissell, Mina J
- Venue
- Nature Clinical Practice Oncology
- Published
- 2008-03-18
- Volume
- 5
- Issue
- 5
- Pages
- 280-290
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- PMC
- PMC2846172
- OpenAlex
- W1972959587
- Cited by
- 253
- References
- 92
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 21 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 18 · 2016: 18 · 2015: 15 · 2014: 16 · 2013: 21 · 2012: 12
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA126552, R13CA113258, R37CA064786, R13CA098946, R01CA064786)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, cellular plasticity, tumor progression, tumor invasion, metastasis, ERK1/ERK2 signaling, PI3K signaling, Ras signaling, tumor microenvironment, fibrosis
- MeSH terms
- Cell Transformation, Neoplastic, Epithelial Cells, Humans, Neoplasms, Neoplastic Processes, Disease Progression, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.